Publications

Back to Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

This activity is supported by an educational grant from AstraZeneca.

Treatment of refractory subacute cutaneous lupus erythematosus with baricitinib

Clin Exp Dermatol. 2021. Epub ahead of print

Four months of baricitinib treatment resulted in rapid improvement of skin manifestations in a 54-year-old male with subacute cutaneous lupus erythematosus.

Keywords:


LinkedIn